Literature DB >> 14654077

Immature B cell malignancies synthesize VEGF, VEGFR-1 (Flt-1) and VEGFR-2 (KDR).

Adila El-Obeid1, Nadia Sunnuqrut, Azhar Hussain, Khalid Al-Hussein, Marina I Gutiérrez, Kishor Bhatia.   

Abstract

Expression of VEGF and VEGFR support a role for angiogenic pathways in the pathogenesis of some hematological malignances. Our goal was to determine if expression of these angiogenic molecules also extend to childhood precursor B cell acute lymphoblastic leukemia (pre-B ALL). We now show that transcripts of VEGF, and its receptors VEGFR-1 and VEGFR-2 are concomitantly expressed in both ALL cell lines and primary pre-B ALL. Western blot and ELISA consistently detected VEGF protein in the supernatants of the cell lines. Similarly, VEGFR-1 and VEGFR-2 proteins are also detectable by FACS analysis. Interestingly, the expression of the receptors in immature B cells is limited to the intra-cytoplasmic compartment and may suggest either internalization of the receptors or a block in trafficking of the receptor to the surface.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14654077     DOI: 10.1016/s0145-2126(03)00188-7

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  5 in total

1.  Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice.

Authors:  Timothy Kottke; Geoff Hall; Jose Pulido; Rosa Maria Diaz; Jill Thompson; Heung Chong; Peter Selby; Matt Coffey; Hardev Pandha; John Chester; Alan Melcher; Kevin Harrington; Richard Vile
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

2.  Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: an immunohistochemical study.

Authors:  Abdullah Hacıhanefioglu; Emel Gonullu; Ozgur Mehtap; Hakan Keski; Melike Yavuz; Cengiz Ercin
Journal:  Med Oncol       Date:  2010-04-27       Impact factor: 3.064

3.  Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome.

Authors:  Elen Oliveira; Elaine S Costa; Juana Ciudad; Giuseppe Gaipa; Łukasz Sedek; Susana Barrena; Tomasz Szczepanski; Chiara Buracchi; Daniela Silvestri; Patrícia F R Siqueira; Fabiana V Mello; Rafael C Torres; Leonardo M R Oliveira; Isabelle V C Fay-Neves; Edwin Sonneveld; Vincent H J van der Velden; Esther Mejstrikova; Josep-Maria Ribera; Valentino Conter; Martin Schrappe; Jacques J M van Dongen; Marcelo G P Land; Alberto Orfao
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

4.  Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Newly Diagnosed Paediatric Acute Lymphoblastic Leukemia.

Authors:  Rachana Meena; Anita Nangia; Sunita Sharma; Jagdish Chandra
Journal:  Indian J Hematol Blood Transfus       Date:  2021-02-23       Impact factor: 0.915

5.  Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease.

Authors:  T Hansen; A Gaumann; M Ghalibafian; A Höferlin; A Heintz; C J Kirkpatrick
Journal:  Virchows Arch       Date:  2004-07-09       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.